Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

QUOTED. 4 July 2019. Walban Damasceno de Souza.

Executive Summary

Anvisa – Brazil's medical technology regulatory agency – has enacted a regulation that allows new devices that are sterilized using ethylene oxide to be certified as sterile under a parametric release protocol. See what Walban Damasceno de Souza of medtech industry association ABIMO said about it here.

“This is a great victory for our industry, which has been suffering from outdated legislation, compared with most other countries. All companies, from the largest, with their own sterilization facilities, to the smallest, which rely on outsourced services, will benefit immediately.” – Walban Damasceno de Souza, senior adviser, ABIMO

Click here for a free trial of Medtech Insight

 

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT125328

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel